Tosto Valentina, Scala Carolina, Fratelli Nicola, Fichera Anna, Familiari Alessandra, Londero Ambrogio Pietro, Ramenghi Luca Antonio, Prefumo Federico
Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Division of Obstetrics and Gynecology, ASST Spedali Civili, 25121 Brescia, Italy.
J Clin Med. 2025 Jul 9;14(14):4876. doi: 10.3390/jcm14144876.
Antenatal corticosteroids are widely used to prevent newborn morbidity and mortality in special obstetric circumstances, especially in preterm birth, but there are ongoing concerns about possible neutral or even detrimental short- and long-term effects in pregnancies complicated by fetal growth restriction. Fetuses with growth restriction may be a subset of preterm infants with a particular vulnerability to steroid exposure. The current scientific evidence on exogenous antenatal corticosteroid effects in this population is not conclusive. Gestational age (early versus late) is a critical issue to assess regarding their use as standard care in this special obstetric circumstance.
产前使用皮质类固醇被广泛用于预防特殊产科情况下的新生儿发病和死亡,尤其是在早产时,但对于合并胎儿生长受限的妊娠,人们一直担心其可能产生的中性甚至有害的短期和长期影响。生长受限的胎儿可能是对类固醇暴露特别敏感的早产儿的一个亚组。目前关于外源性产前皮质类固醇对这一人群影响的科学证据尚无定论。在这种特殊产科情况下,作为标准治疗方法使用皮质类固醇时,胎龄(早期与晚期)是一个需要评估的关键问题。